Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo

Journal of Orthopaedic Research

Volumn 25, Issue 11, 2007, Pages 1488-1497

  Aghaloo, Tara L ^a   Amantea, Christopher M ^b   Cowan, Catherine M ^a   Richardson, Jennifer A ^b   Wu, Ben M ^a   Parhami, Farhad ^b   Tetradis, Sotirios ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone; Healing; Osteoblast; Oxysterol

Indexed keywords

NUCLEAR PROTEIN; OXYSTEROL; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; FRACTURE HEALING; GEL MOBILITY SHIFT ASSAY; IN VIVO STUDY; MALE; NONHUMAN; NORTHERN BLOTTING; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RNA ISOLATION; THREE DIMENSIONAL IMAGING;

ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE REGENERATION; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HYDROXYCHOLESTEROLS; LACTIC ACID; MALE; MICE; OSTEOBLASTS; OSTEOCALCIN; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SKULL; STROMAL CELLS;

EID: 36749091158     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20437     Document Type: Article

References (64)

1. Franceschi RT. 2005. Biological approaches to bone regeneration by gene therapy. J Dent Res 84:1093-1103.
2. Cowan CM, Soo C, Ting K, et al. 2005. Evolving concepts in bone tissue engineering. Curr Top Dev Biol 66:239-285.
3. Ripamonti U, Duneas N, Van Den Heever B, et al. 1997. Recombinant transforming growth factor-beta1 induces endochondral bone in the baboon and synergizes with recombinant osteogenic protein-1 (bone morphogenetic protein-7) to initiate rapid bone formation. J Bone Miner Res 12:1584-1595.
4. Giannobile WV, Hernandez RA, Finkelman RD, et al. 1996. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodontal Res 31:301-312.
5. Blom EJ, Klein-Nulend J, Yin L, et al. 2001. Transforming growth factor-beta1 incorporated in calcium phosphate cement stimulates osteotransductivity in rat calvarial bone defects. Clin Oral Implants Res 12:609-616.
6. Goodman SB, Song Y, Yoo JY, et al. 2003. Local infusion of FGF-2 enhances bone ingrowth in rabbit chambers in the presence of polyethylene particles. J Biomed Mater Res A 65:454-461.
7. Johnson EE, Urist MR. 2000. Human bone morphogenetic protein allografting for reconstruction of femoral non-union. Clin Ortho p 61-74.
8. Govender PV, Rampersaud YR, Rickards L, et al. 2002. Use of osteogenic protein-1 in spinal fusion: literature review and preliminary results in a prospective series of high-risk cases. Neurosurg Focus 13:e4.
9. Minamide A, Yoshida M, Kawakami M, et al. 2005. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine 30:1134-1138.
10. Govender S, Csimma C, Genant HK, et al. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg [Am] 84:2123-2134.
11. Winn SR, Hu Y, Sfeir C, et al. 2000. Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev 42:121-138.
12. Edwards PA, Ericsson J. 1999. Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68:157-185.
13. Bjorkhem I, Diczfalusy U. 2002. Oxysterols: friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol 22:734-742.
14. Bjorkhem I, Reihner E, Angelin B, et al. 1987. On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans. J Lipid Res 28:889-894.
15. Bretillon L, Lutjohann D, Stahle L, et al. 2000. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. J Lipid Res 41:840-845.
16. Bodin K, Andersson U, Rystedt E, et al. 2002. Metabolism of 4 beta -hydroxycholesterol in humans. J Biol Chem 277:31534-31540.
17. Meaney S, Hassan M, Sakinis A, et al. 2001. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study. J Lipid Res 42:70-78.
18. Lyons MA, Samman S, Gatto L, et al. 1999. Rapid hepatic metabolism of 7-ketocholesterol in vivo: implications for dietary oxysterols. J Lipid Res 40:1846-1857.
19. Russell DW. 2000. Oxysterol biosynthetic enzymes. Biochim Biophys Acta 1529:126-135.
20. Schroepfer GJ Jr. 2000. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80:361-554.
21. Parhami F, Mody N, Gharavi N, et al. 2002. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. J Bone Miner Res 17:1997-2003.
22. Kha HT, Basseri B, Shouhed D, et al. 2004. Oxysterols regulate differentiation of mesenchymal stem cells: probone and anti-fat. J Bone Miner Res 19:830-840.
23. Meunier P, Aaron J, Edouard C, et al. 1971. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Ortho p 147-154.
24. Parhami F, Jackson SM, Tintut Y, et al. 1999. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14:2067-2078.
25. Parhami F, Morrow AD, Balucan J, et al. 1997. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680-687.
26. Osborn L, Kunkel S, Nabel GJ. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 86:2336-2340.
27. Ducy P, Zhang R, Geoffroy V, et al. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
28. Cowan C, Aghaloo T, Chou Y, et al. 2005. Nell-1 induced bone formation, fusion, and regeneration. J Bone Miner Res 20 (Suppl 1):S361.
29. Cowan CM, Shi YY, Aalami OO, et al. 2004. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 22:560-567.
30. Zhang X, Kuroda S, Carpenter D, et al. 2002. Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin Invest 110:861-870.
31. Hicok KC, Thomas T, Gori F, et al. 1998. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res 13:205-217.
32. Oldham JB, Lu L, Zhu X, et al. 2000. Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng 122:289-292.
33. Frazza EJ, Schmitt EE. 1971. A new absorbable suture. J Biomed Mater Res 5:43-58.
34. Hartman EH, Spauwen PH, Jansen JA. 2002. Donor-site complications in vascularized bone flap surgery. J Invest Surg 15:185-197.
35. Maeda T, Matsunuma A, Kurahashi I, et al. 2004. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem 92:458-471.
36. Luppen CA, Leclerc N, Noh T, et al. 2003. Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem 278:44995-45003.
37. Li IW, Cheifetz S, McCulloch CA, et al. 1996. Effects of osteogenic protein-1 (OP-1, BMP-7) on bone matrix protein expression by fetal rat calvarial cells are differentiation stage specific. J Cell Physiol 169:115-125.
38. Cortizo AM, Sedlinsky C, McCarthy AD, et al. 2006. Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol 536:38-46.
39. Schiller PC, D'Ippolito G, Roos BA, et al. 1999. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res 14:1504-1512.
40. Stein GS, Lian JB. 1993. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442.
41. Franceschi RT, Xiao G. 2003. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454.
42. Bosch C, Meisen B, Gibbons R, et al. 1996. Human recombinant transforming growth factor-beta 1 in healing of calvarial bone defects. J Craniofac Surg 7:300-310.
43. Lee JY, Musgrave D, Pelinkovic D, et al. 2001. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg [Am] 83:1032-1039.
44. Mehrara BJ, Spector JA, Greenwald JA, et al. 2002. Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion. Plast Reconstr Surg 110:506-514.
45. Ishaug SL, Crane GM, Miller MJ, et al. 1997. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 36:17-28.
46. Woo BH, Fink BF, Page R, et al. 2001. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res 18:1747-1753.
47. Rosen V, Thies RS. 1992. The BMP proteins in bone formation and repair. Trends Genet 8:97-102.
48. Uludag H, Friess W, Williams D, et al. 1999. rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann N Y Acad Sci 875:369-378.
49. Ruhe PQ, Hedberg EL, Padron NT, et al. 2003. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg [Am] 85 (Suppl 3):75-81.
50. Friess W, Uludag H, Foskett S, et al. 1999. Characterization of absorbable collagen sponges as rhBMP-2 carriers. Int J Pharm 187:91-99.
51. Hyun SJ, Han DK, Choi SH, et al. 2005. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects. J Periodontol 76:1667-1674.
52. Gysin R, Wergedal JE, Sheng MH, et al. 2002. Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats. Gene Ther 9:991-999.
53. Lee YM, Park YJ, Lee SJ, et al. 2000. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier. J Periodontol 71:418-424.
54. Nussenbaum B, Rutherford RB, Krebsbach PH., 2005. Bone regeneration in cranial defects previously treated with radiation. Laryngoscope 115:1170-1177.
55. Park YJ, Ku Y, Chung CP, et al. 1998. Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. J Control Release 51:201-211.
56. Miki T, Harada K, Imai Y, et al. 1994. Effect of freeze-dried poly-L-lactic acid discs mixed with bone morphogenetic protein on the healing of rat skull defects. J Oral Maxillofac Surg 52:387-391; discussion 392.
57. Reddi AH. 1995. Bone morphogenetic proteins, bone marrow stromal cells, and mesenchymal stem cells. Maureen Owen revisited. Clin Ortho p 115-119.
58. Lieberman JR, Daluiski A, Einhorn TA. 2002. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg [Am] 84:1032-1044.
59. Katagiri T, Takahashi N. 2002. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8:147-159.
60. van den Bergh JP, ten Bruggenkate CM, Groeneveld HH, et al. 2000. Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. J Clin Periodontol 27:627-636.
61. Tang TT, Xu XL, Dai KR, et al. 2005. Ectopic bone formation of human bone morphogenetic protein-2 gene transfected goat bone marrow-derived mesenchymal stem cells in nude mice. Chin J Traumatol 8:3-7.
62. Majors AK, Boehm CA, Nitto H, et al. 1997. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15:546-557.
63. Bergman RJ, Gazit D, Kahn AJ, et al. 1996. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 11:568-577.
64. Chan GK, Duque G, 2002. Age-related bone loss: old bone, new facts. Gerontology 48:62-71.